nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—ABCB1—ovarian cancer	0.464	1	CbGaD
Lomitapide—ABCB1—Topotecan—ovarian cancer	0.0767	0.221	CbGbCtD
Lomitapide—ABCB1—Vinorelbine—ovarian cancer	0.054	0.156	CbGbCtD
Lomitapide—CYP3A4—Topotecan—ovarian cancer	0.0459	0.133	CbGbCtD
Lomitapide—ABCB1—Paclitaxel—ovarian cancer	0.038	0.11	CbGbCtD
Lomitapide—CYP3A4—Vinorelbine—ovarian cancer	0.0324	0.0935	CbGbCtD
Lomitapide—ABCB1—Docetaxel—ovarian cancer	0.0274	0.0793	CbGbCtD
Lomitapide—CYP3A4—Paclitaxel—ovarian cancer	0.0227	0.0657	CbGbCtD
Lomitapide—ABCB1—Doxorubicin—ovarian cancer	0.0205	0.0591	CbGbCtD
Lomitapide—CYP3A4—Docetaxel—ovarian cancer	0.0164	0.0475	CbGbCtD
Lomitapide—CYP3A4—Doxorubicin—ovarian cancer	0.0123	0.0354	CbGbCtD
Lomitapide—MTTP—embryo—ovarian cancer	0.00721	0.28	CbGeAlD
Lomitapide—MTTP—female reproductive system—ovarian cancer	0.00437	0.17	CbGeAlD
Lomitapide—MTTP—female gonad—ovarian cancer	0.00398	0.154	CbGeAlD
Lomitapide—MTTP—testis—ovarian cancer	0.00353	0.137	CbGeAlD
Lomitapide—ABCB1—myometrium—ovarian cancer	0.000662	0.0257	CbGeAlD
Lomitapide—ABCB1—embryo—ovarian cancer	0.000637	0.0247	CbGeAlD
Lomitapide—CYP3A4—female reproductive system—ovarian cancer	0.000545	0.0211	CbGeAlD
Lomitapide—ABCB1—epithelium—ovarian cancer	0.000519	0.0202	CbGeAlD
Lomitapide—ABCB1—uterine cervix—ovarian cancer	0.000515	0.02	CbGeAlD
Lomitapide—ABCB1—decidua—ovarian cancer	0.000491	0.019	CbGeAlD
Lomitapide—ABCB1—endometrium—ovarian cancer	0.000466	0.0181	CbGeAlD
Lomitapide—ABCB1—gonad—ovarian cancer	0.000432	0.0168	CbGeAlD
Lomitapide—ABCB1—uterus—ovarian cancer	0.000429	0.0167	CbGeAlD
Lomitapide—ABCB1—female reproductive system—ovarian cancer	0.000386	0.015	CbGeAlD
Lomitapide—ABCB1—bone marrow—ovarian cancer	0.000364	0.0141	CbGeAlD
Lomitapide—ABCB1—female gonad—ovarian cancer	0.000351	0.0136	CbGeAlD
Lomitapide—ABCB1—vagina—ovarian cancer	0.000349	0.0135	CbGeAlD
Lomitapide—Urinary tract disorder—Paclitaxel—ovarian cancer	0.000339	0.00207	CcSEcCtD
Lomitapide—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000338	0.00206	CcSEcCtD
Lomitapide—Urethral disorder—Paclitaxel—ovarian cancer	0.000337	0.00206	CcSEcCtD
Lomitapide—Body temperature increased—Topotecan—ovarian cancer	0.000335	0.00205	CcSEcCtD
Lomitapide—Abdominal pain—Topotecan—ovarian cancer	0.000335	0.00205	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000331	0.00202	CcSEcCtD
Lomitapide—Weight decreased—Docetaxel—ovarian cancer	0.000329	0.00201	CcSEcCtD
Lomitapide—Ecchymosis—Doxorubicin—ovarian cancer	0.000327	0.002	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Epirubicin—ovarian cancer	0.000327	0.002	CcSEcCtD
Lomitapide—Diarrhoea—Chlorambucil—ovarian cancer	0.000326	0.00199	CcSEcCtD
Lomitapide—Paraesthesia—Vinorelbine—ovarian cancer	0.000326	0.00199	CcSEcCtD
Lomitapide—Infestation NOS—Docetaxel—ovarian cancer	0.000325	0.00198	CcSEcCtD
Lomitapide—Infestation—Docetaxel—ovarian cancer	0.000325	0.00198	CcSEcCtD
Lomitapide—Eye disorder—Paclitaxel—ovarian cancer	0.000321	0.00196	CcSEcCtD
Lomitapide—Cardiac disorder—Paclitaxel—ovarian cancer	0.000319	0.00195	CcSEcCtD
Lomitapide—Decreased appetite—Vinorelbine—ovarian cancer	0.000316	0.00193	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000313	0.00192	CcSEcCtD
Lomitapide—Fatigue—Vinorelbine—ovarian cancer	0.000313	0.00191	CcSEcCtD
Lomitapide—ABCB1—testis—ovarian cancer	0.000311	0.0121	CbGeAlD
Lomitapide—Constipation—Vinorelbine—ovarian cancer	0.00031	0.0019	CcSEcCtD
Lomitapide—Mediastinal disorder—Paclitaxel—ovarian cancer	0.00031	0.00189	CcSEcCtD
Lomitapide—Chills—Paclitaxel—ovarian cancer	0.000308	0.00188	CcSEcCtD
Lomitapide—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000307	0.00188	CcSEcCtD
Lomitapide—Asthenia—Topotecan—ovarian cancer	0.000304	0.00186	CcSEcCtD
Lomitapide—Vomiting—Chlorambucil—ovarian cancer	0.000303	0.00185	CcSEcCtD
Lomitapide—Increased appetite—Epirubicin—ovarian cancer	0.000302	0.00185	CcSEcCtD
Lomitapide—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.000302	0.00185	CcSEcCtD
Lomitapide—Malnutrition—Paclitaxel—ovarian cancer	0.000299	0.00183	CcSEcCtD
Lomitapide—Feeling abnormal—Vinorelbine—ovarian cancer	0.000299	0.00183	CcSEcCtD
Lomitapide—Asthenia—Melphalan—ovarian cancer	0.000298	0.00182	CcSEcCtD
Lomitapide—Dermatitis bullous—Epirubicin—ovarian cancer	0.000297	0.00182	CcSEcCtD
Lomitapide—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000297	0.00181	CcSEcCtD
Lomitapide—Flatulence—Paclitaxel—ovarian cancer	0.000295	0.0018	CcSEcCtD
Lomitapide—Diarrhoea—Topotecan—ovarian cancer	0.00029	0.00177	CcSEcCtD
Lomitapide—Back pain—Paclitaxel—ovarian cancer	0.000289	0.00177	CcSEcCtD
Lomitapide—Urinary tract disorder—Docetaxel—ovarian cancer	0.000288	0.00176	CcSEcCtD
Lomitapide—Muscle spasms—Paclitaxel—ovarian cancer	0.000288	0.00176	CcSEcCtD
Lomitapide—Body temperature increased—Vinorelbine—ovarian cancer	0.000287	0.00175	CcSEcCtD
Lomitapide—Abdominal pain—Vinorelbine—ovarian cancer	0.000287	0.00175	CcSEcCtD
Lomitapide—Connective tissue disorder—Docetaxel—ovarian cancer	0.000286	0.00175	CcSEcCtD
Lomitapide—Urethral disorder—Docetaxel—ovarian cancer	0.000286	0.00175	CcSEcCtD
Lomitapide—Diarrhoea—Melphalan—ovarian cancer	0.000284	0.00174	CcSEcCtD
Lomitapide—Pain in extremity—Epirubicin—ovarian cancer	0.000284	0.00174	CcSEcCtD
Lomitapide—Nausea—Chlorambucil—ovarian cancer	0.000283	0.00173	CcSEcCtD
Lomitapide—Dizziness—Topotecan—ovarian cancer	0.000281	0.00172	CcSEcCtD
Lomitapide—Increased appetite—Doxorubicin—ovarian cancer	0.00028	0.00171	CcSEcCtD
Lomitapide—Migraine—Epirubicin—ovarian cancer	0.00028	0.00171	CcSEcCtD
Lomitapide—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000278	0.0017	CcSEcCtD
Lomitapide—Anaemia—Paclitaxel—ovarian cancer	0.000277	0.00169	CcSEcCtD
Lomitapide—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000275	0.00168	CcSEcCtD
Lomitapide—Eye disorder—Docetaxel—ovarian cancer	0.000272	0.00166	CcSEcCtD
Lomitapide—Cardiac disorder—Docetaxel—ovarian cancer	0.00027	0.00165	CcSEcCtD
Lomitapide—Vomiting—Topotecan—ovarian cancer	0.00027	0.00165	CcSEcCtD
Lomitapide—Malaise—Paclitaxel—ovarian cancer	0.00027	0.00165	CcSEcCtD
Lomitapide—Vertigo—Paclitaxel—ovarian cancer	0.000269	0.00164	CcSEcCtD
Lomitapide—Headache—Topotecan—ovarian cancer	0.000266	0.00162	CcSEcCtD
Lomitapide—Palpitations—Paclitaxel—ovarian cancer	0.000264	0.00162	CcSEcCtD
Lomitapide—Vomiting—Melphalan—ovarian cancer	0.000264	0.00161	CcSEcCtD
Lomitapide—Dehydration—Epirubicin—ovarian cancer	0.000264	0.00161	CcSEcCtD
Lomitapide—Pain in extremity—Doxorubicin—ovarian cancer	0.000263	0.00161	CcSEcCtD
Lomitapide—Mediastinal disorder—Docetaxel—ovarian cancer	0.000263	0.0016	CcSEcCtD
Lomitapide—Liver function test abnormal—Epirubicin—ovarian cancer	0.000262	0.0016	CcSEcCtD
Lomitapide—Chills—Docetaxel—ovarian cancer	0.000261	0.0016	CcSEcCtD
Lomitapide—Asthenia—Vinorelbine—ovarian cancer	0.00026	0.00159	CcSEcCtD
Lomitapide—Dry skin—Epirubicin—ovarian cancer	0.00026	0.00159	CcSEcCtD
Lomitapide—Abdominal pain upper—Epirubicin—ovarian cancer	0.000259	0.00159	CcSEcCtD
Lomitapide—Migraine—Doxorubicin—ovarian cancer	0.000259	0.00158	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.000256	0.00156	CcSEcCtD
Lomitapide—Chest pain—Paclitaxel—ovarian cancer	0.000255	0.00156	CcSEcCtD
Lomitapide—Myalgia—Paclitaxel—ovarian cancer	0.000255	0.00156	CcSEcCtD
Lomitapide—Arthralgia—Paclitaxel—ovarian cancer	0.000255	0.00156	CcSEcCtD
Lomitapide—Nasopharyngitis—Epirubicin—ovarian cancer	0.000254	0.00155	CcSEcCtD
Lomitapide—Malnutrition—Docetaxel—ovarian cancer	0.000254	0.00155	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000253	0.00155	CcSEcCtD
Lomitapide—Nausea—Topotecan—ovarian cancer	0.000252	0.00154	CcSEcCtD
Lomitapide—Discomfort—Paclitaxel—ovarian cancer	0.000252	0.00154	CcSEcCtD
Lomitapide—Gastritis—Epirubicin—ovarian cancer	0.000251	0.00154	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000251	0.00153	CcSEcCtD
Lomitapide—Dry mouth—Paclitaxel—ovarian cancer	0.000249	0.00152	CcSEcCtD
Lomitapide—Diarrhoea—Vinorelbine—ovarian cancer	0.000248	0.00152	CcSEcCtD
Lomitapide—Abdominal distension—Epirubicin—ovarian cancer	0.000247	0.00151	CcSEcCtD
Lomitapide—Nausea—Melphalan—ovarian cancer	0.000247	0.00151	CcSEcCtD
Lomitapide—Influenza—Epirubicin—ovarian cancer	0.000245	0.0015	CcSEcCtD
Lomitapide—Back pain—Docetaxel—ovarian cancer	0.000245	0.0015	CcSEcCtD
Lomitapide—Dehydration—Doxorubicin—ovarian cancer	0.000244	0.00149	CcSEcCtD
Lomitapide—Muscle spasms—Docetaxel—ovarian cancer	0.000244	0.00149	CcSEcCtD
Lomitapide—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000243	0.00148	CcSEcCtD
Lomitapide—Infection—Paclitaxel—ovarian cancer	0.000243	0.00148	CcSEcCtD
Lomitapide—Dry skin—Doxorubicin—ovarian cancer	0.000241	0.00147	CcSEcCtD
Lomitapide—Dizziness—Vinorelbine—ovarian cancer	0.00024	0.00147	CcSEcCtD
Lomitapide—Abdominal pain upper—Doxorubicin—ovarian cancer	0.00024	0.00147	CcSEcCtD
Lomitapide—Nervous system disorder—Paclitaxel—ovarian cancer	0.000239	0.00146	CcSEcCtD
Lomitapide—Angina pectoris—Epirubicin—ovarian cancer	0.000239	0.00146	CcSEcCtD
Lomitapide—Skin disorder—Paclitaxel—ovarian cancer	0.000237	0.00145	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.000237	0.00145	CcSEcCtD
Lomitapide—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000236	0.00144	CcSEcCtD
Lomitapide—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000235	0.00144	CcSEcCtD
Lomitapide—Anaemia—Docetaxel—ovarian cancer	0.000234	0.00143	CcSEcCtD
Lomitapide—Gastritis—Doxorubicin—ovarian cancer	0.000233	0.00142	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000232	0.00142	CcSEcCtD
Lomitapide—Vomiting—Vinorelbine—ovarian cancer	0.000231	0.00141	CcSEcCtD
Lomitapide—Abdominal distension—Doxorubicin—ovarian cancer	0.000229	0.0014	CcSEcCtD
Lomitapide—Headache—Vinorelbine—ovarian cancer	0.000227	0.00139	CcSEcCtD
Lomitapide—Influenza—Doxorubicin—ovarian cancer	0.000227	0.00139	CcSEcCtD
Lomitapide—ABCB1—lymph node—ovarian cancer	0.000226	0.00876	CbGeAlD
Lomitapide—Palpitations—Docetaxel—ovarian cancer	0.000224	0.00137	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000222	0.00136	CcSEcCtD
Lomitapide—Weight decreased—Epirubicin—ovarian cancer	0.000222	0.00136	CcSEcCtD
Lomitapide—Angina pectoris—Doxorubicin—ovarian cancer	0.000221	0.00135	CcSEcCtD
Lomitapide—Paraesthesia—Paclitaxel—ovarian cancer	0.000219	0.00134	CcSEcCtD
Lomitapide—Infestation NOS—Epirubicin—ovarian cancer	0.000219	0.00134	CcSEcCtD
Lomitapide—Infestation—Epirubicin—ovarian cancer	0.000219	0.00134	CcSEcCtD
Lomitapide—Somnolence—Paclitaxel—ovarian cancer	0.000217	0.00133	CcSEcCtD
Lomitapide—Myalgia—Docetaxel—ovarian cancer	0.000216	0.00132	CcSEcCtD
Lomitapide—Chest pain—Docetaxel—ovarian cancer	0.000216	0.00132	CcSEcCtD
Lomitapide—Arthralgia—Docetaxel—ovarian cancer	0.000216	0.00132	CcSEcCtD
Lomitapide—Nausea—Vinorelbine—ovarian cancer	0.000216	0.00132	CcSEcCtD
Lomitapide—Dyspepsia—Paclitaxel—ovarian cancer	0.000215	0.00131	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000214	0.00131	CcSEcCtD
Lomitapide—Decreased appetite—Paclitaxel—ovarian cancer	0.000212	0.0013	CcSEcCtD
Lomitapide—Dry mouth—Docetaxel—ovarian cancer	0.000211	0.00129	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000211	0.00129	CcSEcCtD
Lomitapide—Fatigue—Paclitaxel—ovarian cancer	0.000211	0.00129	CcSEcCtD
Lomitapide—Constipation—Paclitaxel—ovarian cancer	0.000209	0.00128	CcSEcCtD
Lomitapide—Haematuria—Epirubicin—ovarian cancer	0.000209	0.00128	CcSEcCtD
Lomitapide—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000207	0.00127	CcSEcCtD
Lomitapide—Infection—Docetaxel—ovarian cancer	0.000206	0.00126	CcSEcCtD
Lomitapide—Weight decreased—Doxorubicin—ovarian cancer	0.000205	0.00126	CcSEcCtD
Lomitapide—Sinusitis—Epirubicin—ovarian cancer	0.000205	0.00126	CcSEcCtD
Lomitapide—Nervous system disorder—Docetaxel—ovarian cancer	0.000203	0.00124	CcSEcCtD
Lomitapide—Infestation—Doxorubicin—ovarian cancer	0.000203	0.00124	CcSEcCtD
Lomitapide—Infestation NOS—Doxorubicin—ovarian cancer	0.000203	0.00124	CcSEcCtD
Lomitapide—Feeling abnormal—Paclitaxel—ovarian cancer	0.000201	0.00123	CcSEcCtD
Lomitapide—Skin disorder—Docetaxel—ovarian cancer	0.000201	0.00123	CcSEcCtD
Lomitapide—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.0002	0.00122	CcSEcCtD
Lomitapide—Urinary tract disorder—Epirubicin—ovarian cancer	0.000194	0.00119	CcSEcCtD
Lomitapide—Haematuria—Doxorubicin—ovarian cancer	0.000193	0.00118	CcSEcCtD
Lomitapide—Connective tissue disorder—Epirubicin—ovarian cancer	0.000193	0.00118	CcSEcCtD
Lomitapide—Body temperature increased—Paclitaxel—ovarian cancer	0.000193	0.00118	CcSEcCtD
Lomitapide—Abdominal pain—Paclitaxel—ovarian cancer	0.000193	0.00118	CcSEcCtD
Lomitapide—Urethral disorder—Epirubicin—ovarian cancer	0.000193	0.00118	CcSEcCtD
Lomitapide—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000192	0.00117	CcSEcCtD
Lomitapide—Sinusitis—Doxorubicin—ovarian cancer	0.00019	0.00116	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000189	0.00115	CcSEcCtD
Lomitapide—Paraesthesia—Docetaxel—ovarian cancer	0.000186	0.00114	CcSEcCtD
Lomitapide—Somnolence—Docetaxel—ovarian cancer	0.000184	0.00112	CcSEcCtD
Lomitapide—Eye disorder—Epirubicin—ovarian cancer	0.000184	0.00112	CcSEcCtD
Lomitapide—Cardiac disorder—Epirubicin—ovarian cancer	0.000182	0.00111	CcSEcCtD
Lomitapide—Dyspepsia—Docetaxel—ovarian cancer	0.000182	0.00111	CcSEcCtD
Lomitapide—Decreased appetite—Docetaxel—ovarian cancer	0.00018	0.0011	CcSEcCtD
Lomitapide—Urinary tract disorder—Doxorubicin—ovarian cancer	0.00018	0.0011	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000179	0.00109	CcSEcCtD
Lomitapide—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000179	0.00109	CcSEcCtD
Lomitapide—Fatigue—Docetaxel—ovarian cancer	0.000178	0.00109	CcSEcCtD
Lomitapide—Urethral disorder—Doxorubicin—ovarian cancer	0.000178	0.00109	CcSEcCtD
Lomitapide—Mediastinal disorder—Epirubicin—ovarian cancer	0.000177	0.00108	CcSEcCtD
Lomitapide—Constipation—Docetaxel—ovarian cancer	0.000177	0.00108	CcSEcCtD
Lomitapide—Chills—Epirubicin—ovarian cancer	0.000176	0.00108	CcSEcCtD
Lomitapide—Asthenia—Paclitaxel—ovarian cancer	0.000175	0.00107	CcSEcCtD
Lomitapide—Malnutrition—Epirubicin—ovarian cancer	0.000171	0.00105	CcSEcCtD
Lomitapide—Feeling abnormal—Docetaxel—ovarian cancer	0.000171	0.00104	CcSEcCtD
Lomitapide—Eye disorder—Doxorubicin—ovarian cancer	0.00017	0.00104	CcSEcCtD
Lomitapide—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000169	0.00103	CcSEcCtD
Lomitapide—Cardiac disorder—Doxorubicin—ovarian cancer	0.000169	0.00103	CcSEcCtD
Lomitapide—Flatulence—Epirubicin—ovarian cancer	0.000169	0.00103	CcSEcCtD
Lomitapide—Diarrhoea—Paclitaxel—ovarian cancer	0.000167	0.00102	CcSEcCtD
Lomitapide—Back pain—Epirubicin—ovarian cancer	0.000165	0.00101	CcSEcCtD
Lomitapide—Muscle spasms—Epirubicin—ovarian cancer	0.000164	0.00101	CcSEcCtD
Lomitapide—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000164	0.001	CcSEcCtD
Lomitapide—Body temperature increased—Docetaxel—ovarian cancer	0.000164	0.001	CcSEcCtD
Lomitapide—Abdominal pain—Docetaxel—ovarian cancer	0.000164	0.001	CcSEcCtD
Lomitapide—Chills—Doxorubicin—ovarian cancer	0.000163	0.000997	CcSEcCtD
Lomitapide—Dizziness—Paclitaxel—ovarian cancer	0.000161	0.000987	CcSEcCtD
Lomitapide—Ill-defined disorder—Epirubicin—ovarian cancer	0.000159	0.00097	CcSEcCtD
Lomitapide—Malnutrition—Doxorubicin—ovarian cancer	0.000158	0.000967	CcSEcCtD
Lomitapide—Anaemia—Epirubicin—ovarian cancer	0.000158	0.000966	CcSEcCtD
Lomitapide—Flatulence—Doxorubicin—ovarian cancer	0.000156	0.000953	CcSEcCtD
Lomitapide—Vomiting—Paclitaxel—ovarian cancer	0.000155	0.000949	CcSEcCtD
Lomitapide—Malaise—Epirubicin—ovarian cancer	0.000154	0.000943	CcSEcCtD
Lomitapide—Vertigo—Epirubicin—ovarian cancer	0.000154	0.000939	CcSEcCtD
Lomitapide—Back pain—Doxorubicin—ovarian cancer	0.000153	0.000936	CcSEcCtD
Lomitapide—Headache—Paclitaxel—ovarian cancer	0.000153	0.000935	CcSEcCtD
Lomitapide—Muscle spasms—Doxorubicin—ovarian cancer	0.000152	0.00093	CcSEcCtD
Lomitapide—Palpitations—Epirubicin—ovarian cancer	0.000151	0.000924	CcSEcCtD
Lomitapide—Asthenia—Docetaxel—ovarian cancer	0.000148	0.000908	CcSEcCtD
Lomitapide—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000147	0.000897	CcSEcCtD
Lomitapide—Anaemia—Doxorubicin—ovarian cancer	0.000146	0.000894	CcSEcCtD
Lomitapide—Myalgia—Epirubicin—ovarian cancer	0.000146	0.00089	CcSEcCtD
Lomitapide—Chest pain—Epirubicin—ovarian cancer	0.000146	0.00089	CcSEcCtD
Lomitapide—Arthralgia—Epirubicin—ovarian cancer	0.000146	0.00089	CcSEcCtD
Lomitapide—Nausea—Paclitaxel—ovarian cancer	0.000145	0.000886	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000145	0.000884	CcSEcCtD
Lomitapide—Discomfort—Epirubicin—ovarian cancer	0.000144	0.000879	CcSEcCtD
Lomitapide—Malaise—Doxorubicin—ovarian cancer	0.000143	0.000872	CcSEcCtD
Lomitapide—Dry mouth—Epirubicin—ovarian cancer	0.000142	0.00087	CcSEcCtD
Lomitapide—Vertigo—Doxorubicin—ovarian cancer	0.000142	0.000869	CcSEcCtD
Lomitapide—Diarrhoea—Docetaxel—ovarian cancer	0.000142	0.000865	CcSEcCtD
Lomitapide—Palpitations—Doxorubicin—ovarian cancer	0.00014	0.000855	CcSEcCtD
Lomitapide—Infection—Epirubicin—ovarian cancer	0.000139	0.000848	CcSEcCtD
Lomitapide—Nervous system disorder—Epirubicin—ovarian cancer	0.000137	0.000837	CcSEcCtD
Lomitapide—Dizziness—Docetaxel—ovarian cancer	0.000137	0.000836	CcSEcCtD
Lomitapide—Skin disorder—Epirubicin—ovarian cancer	0.000136	0.000829	CcSEcCtD
Lomitapide—Hyperhidrosis—Epirubicin—ovarian cancer	0.000135	0.000825	CcSEcCtD
Lomitapide—Myalgia—Doxorubicin—ovarian cancer	0.000135	0.000824	CcSEcCtD
Lomitapide—Chest pain—Doxorubicin—ovarian cancer	0.000135	0.000824	CcSEcCtD
Lomitapide—Arthralgia—Doxorubicin—ovarian cancer	0.000135	0.000824	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000134	0.000818	CcSEcCtD
Lomitapide—Discomfort—Doxorubicin—ovarian cancer	0.000133	0.000814	CcSEcCtD
Lomitapide—Dry mouth—Doxorubicin—ovarian cancer	0.000132	0.000805	CcSEcCtD
Lomitapide—Vomiting—Docetaxel—ovarian cancer	0.000132	0.000804	CcSEcCtD
Lomitapide—Headache—Docetaxel—ovarian cancer	0.00013	0.000792	CcSEcCtD
Lomitapide—Infection—Doxorubicin—ovarian cancer	0.000128	0.000784	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000127	0.000777	CcSEcCtD
Lomitapide—Nervous system disorder—Doxorubicin—ovarian cancer	0.000127	0.000774	CcSEcCtD
Lomitapide—Skin disorder—Doxorubicin—ovarian cancer	0.000125	0.000767	CcSEcCtD
Lomitapide—Paraesthesia—Epirubicin—ovarian cancer	0.000125	0.000766	CcSEcCtD
Lomitapide—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000125	0.000763	CcSEcCtD
Lomitapide—Somnolence—Epirubicin—ovarian cancer	0.000124	0.000758	CcSEcCtD
Lomitapide—Nausea—Docetaxel—ovarian cancer	0.000123	0.000751	CcSEcCtD
Lomitapide—Dyspepsia—Epirubicin—ovarian cancer	0.000123	0.000751	CcSEcCtD
Lomitapide—Decreased appetite—Epirubicin—ovarian cancer	0.000121	0.000742	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000121	0.000737	CcSEcCtD
Lomitapide—Fatigue—Epirubicin—ovarian cancer	0.00012	0.000736	CcSEcCtD
Lomitapide—Constipation—Epirubicin—ovarian cancer	0.000119	0.00073	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000118	0.000719	CcSEcCtD
Lomitapide—Paraesthesia—Doxorubicin—ovarian cancer	0.000116	0.000709	CcSEcCtD
Lomitapide—Feeling abnormal—Epirubicin—ovarian cancer	0.000115	0.000703	CcSEcCtD
Lomitapide—Somnolence—Doxorubicin—ovarian cancer	0.000115	0.000702	CcSEcCtD
Lomitapide—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000114	0.000698	CcSEcCtD
Lomitapide—Dyspepsia—Doxorubicin—ovarian cancer	0.000114	0.000695	CcSEcCtD
Lomitapide—Decreased appetite—Doxorubicin—ovarian cancer	0.000112	0.000686	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000112	0.000682	CcSEcCtD
Lomitapide—Fatigue—Doxorubicin—ovarian cancer	0.000111	0.000681	CcSEcCtD
Lomitapide—Constipation—Doxorubicin—ovarian cancer	0.00011	0.000675	CcSEcCtD
Lomitapide—Abdominal pain—Epirubicin—ovarian cancer	0.00011	0.000674	CcSEcCtD
Lomitapide—Body temperature increased—Epirubicin—ovarian cancer	0.00011	0.000674	CcSEcCtD
Lomitapide—Feeling abnormal—Doxorubicin—ovarian cancer	0.000106	0.000651	CcSEcCtD
Lomitapide—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000106	0.000646	CcSEcCtD
Lomitapide—Abdominal pain—Doxorubicin—ovarian cancer	0.000102	0.000624	CcSEcCtD
Lomitapide—Body temperature increased—Doxorubicin—ovarian cancer	0.000102	0.000624	CcSEcCtD
Lomitapide—Asthenia—Epirubicin—ovarian cancer	0.0001	0.000612	CcSEcCtD
Lomitapide—Diarrhoea—Epirubicin—ovarian cancer	9.55e-05	0.000584	CcSEcCtD
Lomitapide—Asthenia—Doxorubicin—ovarian cancer	9.27e-05	0.000566	CcSEcCtD
Lomitapide—Dizziness—Epirubicin—ovarian cancer	9.23e-05	0.000564	CcSEcCtD
Lomitapide—Vomiting—Epirubicin—ovarian cancer	8.88e-05	0.000542	CcSEcCtD
Lomitapide—Diarrhoea—Doxorubicin—ovarian cancer	8.84e-05	0.00054	CcSEcCtD
Lomitapide—Headache—Epirubicin—ovarian cancer	8.75e-05	0.000535	CcSEcCtD
Lomitapide—Dizziness—Doxorubicin—ovarian cancer	8.54e-05	0.000522	CcSEcCtD
Lomitapide—Nausea—Epirubicin—ovarian cancer	8.29e-05	0.000507	CcSEcCtD
Lomitapide—Vomiting—Doxorubicin—ovarian cancer	8.21e-05	0.000502	CcSEcCtD
Lomitapide—Headache—Doxorubicin—ovarian cancer	8.09e-05	0.000495	CcSEcCtD
Lomitapide—Nausea—Doxorubicin—ovarian cancer	7.67e-05	0.000469	CcSEcCtD
